Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inresa Arzneimittel is a specialized German pharmaceutical company headquartered in Freiburg im Breisgau, focusing on the supply of niche medicinal products and hospital-essential drugs. Established in 1993, the company has built a robust portfolio centered on anesthesiology, intensive care, oncology, and rare diseases. Inresa is particularly recognized for its expertise in providing high-quality generic injectables and hard-to-find medications for clinical use. The company serves as a critical partner for hospitals and pharmacies across Europe, ensuring the availability of vital therapies. Their business model emphasizes reliability in the supply chain for specialized therapeutic segments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inresa Arzneimittel.